Single-Fraction Stereotactic Body Radiotherapy for Localized Prostate Cancer

Дата публикации: 18-06-2026 00:00:00

This nonrandomized clinical trial evaluates the efficacy and tolerance of single-fraction stereotactic body radiotherapy in men with localized prostate cancer.

Схожие новости

#	Наименование новости	Тональность	Информативность	Дата публикации
1	Disitamab Vedotin Plus Tislelizumab in Non–Muscle-Invasive Bladder Cancer	0	13.81	08-10-2026
2	Race, Secondary Treatment, and Survival in Localized Prostate Cancer	0	5.24	21-07-2026
3	Pembrolizumab Plus Quad-Shot Radiotherapy for Recurrent, Unresectable, or Metastatic Head and Neck Cancer	0	8.64	01-08-2026
4	Preoperative High-Dose Corticosteroids in Digestive Cancer Surgery	0	9.7	19-08-2026
5	Transarterial Chemoembolization Plus Thermal Ablation in Unresectable Hepatocellular Carcinoma	0	5.96	30-07-2026
6	Long-Term Adverse Effects and Complications After Prostate Cancer Treatment	0	9.73	01-12-2024
7	Medically Assisted Reproduction and Hormone-Related Cancers	0	5	13-07-2026
8	Bispecific Antibody Ivonescimab Added to Chemotherapy in EGFR -Variant Non–Small Cell Lung Cancer	0	10	28-07-2026
9	Prostate Cancer Mortality After Relabeling Low-Grade Prostate Cancer as Precancerous	0	9.66	01-07-2026
10	Neoadjuvant Paclitaxel, Trastuzumab, and Pertuzumab for Stage II to III, ERBB2 -Positive Breast Cancer	0	7	25-06-2026

Классификация: Наука. Схожих патентов: 0. Схожих новостей: 10. Тональность: 0. Информативность: 5. Источник: jamanetwork.com.